REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 81 filers reported holding REPARE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $40,135,655 | +14.2% | 3,322,488 | 0.0% | 0.85% | +33.9% |
Q2 2023 | $35,151,923 | +7.5% | 3,322,488 | 0.0% | 0.64% | -0.8% |
Q1 2023 | $32,693,282 | -33.1% | 3,322,488 | 0.0% | 0.64% | -31.3% |
Q4 2022 | $48,873,798 | +21.3% | 3,322,488 | 0.0% | 0.94% | +25.0% |
Q3 2022 | $40,302,000 | -13.3% | 3,322,488 | 0.0% | 0.75% | -11.2% |
Q2 2022 | $46,482,000 | -1.8% | 3,322,488 | 0.0% | 0.84% | +9.8% |
Q1 2022 | $47,312,000 | -32.5% | 3,322,488 | 0.0% | 0.77% | -14.9% |
Q4 2021 | $70,071,000 | -19.6% | 3,322,488 | 0.0% | 0.90% | -5.9% |
Q3 2021 | $87,182,000 | -18.4% | 3,322,488 | -3.0% | 0.96% | -11.4% |
Q2 2021 | $106,833,000 | +1.6% | 3,426,325 | 0.0% | 1.08% | +10.0% |
Q1 2021 | $105,154,000 | -10.5% | 3,426,325 | 0.0% | 0.98% | -4.4% |
Q4 2020 | $117,523,000 | +11.5% | 3,426,325 | 0.0% | 1.03% | -22.4% |
Q3 2020 | $105,428,000 | -0.8% | 3,426,325 | 0.0% | 1.32% | -11.4% |
Q2 2020 | $106,285,000 | – | 3,426,325 | – | 1.50% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 2,646,657 | $31,971,617 | 17.00% |
MPM ASSET MANAGEMENT LLC | 2,242,636 | $27,091,043 | 14.51% |
CHI Advisors LLC | 2,966,674 | $35,837,422 | 14.20% |
MPM BioImpact LLC | 1,639,849 | $19,809,376 | 5.29% |
BVF INC/IL | 8,291,988 | $100,167,215 | 2.70% |
Deep Track Capital, LP | 3,067,731 | $37,058,190 | 1.43% |
Redmile Group, LLC | 2,404,695 | $29,048,716 | 1.38% |
HighVista Strategies LLC | 165,173 | $1,995,290 | 0.92% |
Orbimed Advisors | 3,322,488 | $40,135,655 | 0.85% |
Logos Global Management LP | 500,000 | $6,040,000 | 0.81% |